NCT05509101 Improving Myoelectric Prosthetic and Orthotic Limb Control
| NCT ID | NCT05509101 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Utah |
| Condition | Hemiparesis |
| Study Type | INTERVENTIONAL |
| Enrollment | 45 participants |
| Start Date | 2017-03-01 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 45 participants in total. It began in 2017-03-01 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to improve control of myoelectrically-controlled advanced orthotic devices (an exoskeleton device that use the body's muscle signals to drive movements of a robotic brace) by using advanced predictive decode algorithms, and the use of high count (\> 8) surface electromyographic (sEMG) electrodes.
Eligibility Criteria
Inclusion Criteria: * First-ever ischemic or hemorrhagic stroke * Chronic Stroke (at least 6 months since onset) * Chronic hemiparesis * Functional range of motion for contralateral arm Exclusion Criteria: * Individuals who are currently Incarcerated
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05509101 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Hemiparesis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05509101 currently recruiting?
Yes, NCT05509101 is actively recruiting participants. Contact the research team at heidi.hansen@hsc.utah.edu for enrollment information.
Where is the NCT05509101 trial being conducted?
This trial is being conducted at Salt Lake City, United States.
Who is sponsoring the NCT05509101 clinical trial?
NCT05509101 is sponsored by University of Utah. The trial plans to enroll 45 participants.